Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: Implications for human breast cancer

EMBO Journal

Volumn 18, Issue 8, 1999, Pages 2149-2164

  Siegel, Peter M ^a,b   Ryan, Eamonn D ^b   Cardiff, Robert D ^c   Muller, William J ^a,b  

^a Inst for Molec Biol and Biotech   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Activating mutations; ErbB receptors; Mammary tumorigenesis; Transgenic mice

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BREAST TUMOR; CARCINOGENESIS; FIBROBLAST; GENE ACTIVATION; GENE DELETION; GENE EXPRESSION; GENE MUTATION; MOUSE; NONHUMAN; ONCOGENE NEU; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; TRANSGENIC MOUSE;

EID: 0033561296     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/18.8.2149     Document Type: Article

References (86)

1. Abe, Y., Odaka, M., Inagaki, F., Lax, I., Schlessinger, J. and Kohda, D. (1998) Disulfide bond structure of human epidermal growth factor receptor. J. Biol. Chem., 273, 11150-11157.
2. Alimandi, M., Romano, A., Curia, M.C., Muraro, R., Fedi, P., Aaronson, S.A., Di Fiore, P.P. and Kraus, M.H. (1995) Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas. Oncogene, 10, 1813-1821.
3. Andrulis, I.L. et al. (1998) neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. J. Clin. Oncol., 16, 1340-1349.
4. Asai, N., Iwashita, T., Matsuyama, M. and Takahashi, M. (1995) Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations. Mol. Cell. Biol., 15, 1613-1619.
5. Bacus, S.S., Zelnick, C.R., Plowman, G. and Yarden, Y. (1994) Expression of the erbB-2 family of growth factor receptors and their ligands in breast cancers. Am. J. Clin. Pathol., 102 (Suppl 1), S13-S24.
6. Bargmann, C.I. and Weinberg, R.A. (1988) Increased tyrosine kinase activity associated with the protein encoded by the activated neu oncogene. Proc. Natl Acad. Sci. USA, 85, 5394-5398.
7. Bargmann, C.I., Hung, M.-C. and Weinberg, R.A. (1986a) The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature, 319, 226-230.
8. Bargmann, C.I., Hung, M.-C. and Weinberg, R.A, (1986b) Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell, 45, 649-657.
9. Bodey, B., Bodey, B.,Jr, Groger, A.M., Luck, J.V., Siegel, S.E., Taylor, C.R. and Kaiser, H.E. (1997) Clinical and prognostic significance of the expression of the c-erbB-2 and c-erbB-3 oncoproteins in primary and metastatic malignant melanomas and breast carcinomas. AntiCancer Res, 17, 1319-1330.
10. Bouchard, L., Lamarre, L., Tremblay, P.J. and Jolicoeur, P. (1989) Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene. Cell, 57, 931-936.
11. Brûlet, P., Babinet, C., Kemler, R. and Jacob, F. (1980) Monoclonal antibodies against trophectoderm-specific markers during blastocyst formation. Proc. Natl Acad. Sci. USA, 77, 4113-4117.
12. Cardiff, R.D., Sinn, E., Muller, W. and Leder, P. (1991) Transgenic oncogene mice. Am. J. Pathol., 139, 495-501.
13. Cohen, B.D., Kiener, P.A., Green, J.M., Foy, L., Fell, H.P. and Zhang, K. (1996) The relationship between human epidermal growth-like factor receptor expression and cellular transformation in NIH3T3 cells. J. Biol. Chem., 271, 30897-30903.
14. Collesi, C., Santoro, M.M., Gaudino, G. and Comoglio, P.M. (1996) A splicing variant of the Ron transcript induces constitutive tyrosine kinase activity and an invasive phenotype. Mol. Cell. Biol., 16, 5518-5526.
15. Coulier, F., Kumar, R., Ernst, M., Klein, R., Martin-Zanca, D. and Barbacid, M. (1990) Human trk oncogenes activated by point mutation, in-frame deletion and duplication of the tyrosine kinase domain. Mol. Cell. Biol., 10, 4202-4210.
16. Coussens, L. et al. (1985) Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science, 230, 1132-1139.
17. Dudek, H., Datta, S.R., Franke, T.F, Birnbaum, M.J., Yao, R., Cooper, G.M., Segal, R.A., Kaplan, D.R. and Greenberg, M.E. (1997) Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science, 275, 661-664.
18. Fedi, P., Pierce, J.H., Di Fiore, P.P. and Kraus, M.H. (1994) Efficient coupling with phosphatidylinositol 3-kinase, but not phospholipase Cγ or GTPase-activating protein, distinguishes ErbB-3 signaling from that of other ErbB/EGFR family members. Mol. Cell. Biol., 14, 492-500.
19. Galvin, B.D., Hart, K.C, Meyer, A.N., Webster, M.K. and Donoghue, D.J. (1996) Constitutive receptor activation by Crouzon syndrome mutations in fibroblast growth factor receptor (FGFR) 2 and FGFR2/ Neu chimeras. Proc. Natl Acad. Sci. USA, 93, 7894-7899.
20. Gasparini, G. et al. (1994) c-erbB-3 and c-erfcB-2 protein expression in node-negative breast carcinoma - an immunocytochemical study. Eur. J. Cancer, 30A, 16-22.
21. Gingras, A.-C, Kennedy, S.G., O'Leary, M.A., Sonenberg, N. and Hay, N. (1998) 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt (PKB) signaling pathway, Genes Dev., 12, 502-513.
22. Gullick, W.J., Love, S.B., Wright, C., Barnes, D.M., Gusterson, B., Harris, A.L. and Altman, D.G. (1991) C-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes. Br. J. Cancer, 63, 434-438.
23. Guy, C.T., Webster, M.A., Schaller, M., Parsons, T.J., Cardiff, R.D. and Muller, W.J. (1992a) Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc. Natl Acad Sci. USA, 89, 10578-10582.
24. Guy, C.T., Cardiff, R.D. and Muller, W.J. (1992b) Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol. Cell. Biol., 12, 954-961.
25. Guy, C.T., Cardiff, R.D. and Muller, W.J. (1996) Activated neu induces rapid tumor progression. J. Biol. Chem., 271, 7673-7678.
26. erbB3 possesses an impaired tyrosine kinase activity. Proc. Natl Acad. Sci. USA, 91, 8132-8136.
27. Karunagaran, D., Tzahar, E., Beerli, R.R., Chen, X., Graus-Porta, D., Ratzkin, B.J., Seger, R., Hynes, N.E. and Yarden, Y. (1996) ErbB-2 is a common auxiliary Subunit of NDF and EGF receptors: implications for breast cancer. EMBO J., 15, 254-264.
28. Kauffman-Zeh, A., Rodriguez-Viciana, P., Ulrich, E., Gilbert, C., Coffer, P., Downward, J. and Evan, G. (1997) Suppression of c-Myc-induced apoptosis by Ras signalling through PI (3)K and PKB. Nature, 385, 544-548.
29. Kemler, R., Brulet, P., Schnebelen, M.-T., Gaillard, J. and Jacob, F. (1981) Reactivity of monoclonal antibodies against intermediate filament proteins during embryonic development. J. Embryol. Exp. Morphol., 64, 45-60.
30. Kennedy, S.G., Wagner, A.J., Conzen, S.D., Jordan, J., Bellacosa, A., Tsichlis, P.N. and Hay, N. (1997) The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev., 11, 701-713.
31. Khwaja, A., Rodriguez-Viciana, P., Wennstrom, S., Warme, P.H. and Downward, J. (1997) Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt survival pathway. EMBO J., 16, 2783-2793.
32. Kim, H.-H., Sierke, S.L. and Koland, J.G. (1994) Epidermal growth factor-dependent association of phosphatidylinositol 3-kinase with the erbB-3 gene product. J. Biol. Chem., 269, 24747-24755.
33. Kitsberg, D.I. and Leder, P. (1996) Keratinocyte growth factor induces mammary and prostatic hyperplasia and mammary adenocarcinoma in transgenic mice. Oncogene, 13, 2507-2515.
34. Kokai, Y., Myers, J.N., Wada, T., Brown, V.I., LeVea, C.M., Davis, J.G., Dobashi, K. and Greene, M.I. (1989) Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts. Cell, 58, 287-292.
35. Kraus, M.H., Issing, W., Miki, T., Popescu, N.C. and Aaronson, S.A. (1989) Isolation and characterization of ERBB3, a third member of the ERBBI epidermal growth factor family: evidence for overexpression in a subset of human mammary tumors. Proc. Natl Acad. Sci. USA, 86, 9193-9197.
36. Kulik, G., Klippel, A. and Weber, M.J. (1997) Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase and Akt. Mol. Cell. Biol., 17, 1595-1606.
37. Kwong, K.Y. and Hung, M.C. (1998) A novel splice variant of HER2 with increased transformation activity. Mol. Carcinogen., 23, 62-68.
38. Lemoine, N.R., Staddon, S., Dickson, C., Barnes, D.M. and Gullick, W.J. (1990) Absence of activating transmembrane mutations in the c-erbB-2 proto-oncogene in human breast cancer. Oncogene, 5, 237-239.
39. Lemoine, N.R., Barnes, D.M., Hollywood, D.P., Hughes, C.M., Smith, P., Dublin, E., Prigent, S.A., Gullick, W.J. and Hurst, H.C. (1992) Expression of the ERBB3 gene product in breast cancer. Br. J. Cancer, 66, 1116-1121.
40. Li, X., Park, W.-J., Pyeritz, R.E. and Jabs, E.W. (1995) Effect on splicing of a silent FGFR2 mutation in Crouzon syndrome. Nature Genet., 9, 232-233.
41. Lucchini, F. et al. (1992) Early and multifocal tumors in breast, salivary, Harderian and epididymal tissues developed in MMTV-Neu transgenic mice. Cancer Lett., 64, 203-209.
42. Meyers, G.A. et al. (1996) FGRF2 exon IIIa and IIIc mutations in Crouzon, Jackson-Weiss and Pfeiffer syndromes: evidence for missense changes, insertions and a deletion due to alternative RNA splicing. Am. J. Hum. Genet., 58, 491-498.
43. Morgenstern, J.P. and Land, H. (1990) A series of mammalian expression vectors and characterization of their expression of a reporter gene in stably and transiently transfected cells. Nucleic Acids Res., 18, 1068.
44. Morita, T., Tondella, M.L.C., Takemoto, Y., Hashido, K., Ichinose, Y., Nozaki, M. and Matsushiro, A. (1988) Nucleotide sequence of mouse Endo A cytokeratin cDNA reveals polypeptide characteristics of the type-II keratin subfamily. Gene, 68, 109-117.
45. Muller, W.J., Sinn, E., Pattengale, P.K., Wallace, R. and Leder, P. (1988) Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell. 54, 105-115.
46. Muller, W.J. et al (1996) Synergistic interaction of the Neu proto-oncogene product and transforming growth factor α in the mammary epithelium of transgenic mice. Mol. Cell. Biol., 16, 5726-5736.
47. Mulligan, L.M. et al. (1993) Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature, 363, 458-460.
48. Muthuswamy, S.K., Siegel, P.M., Dankort, D.L., Webster, M.A. and Muller, W.J. (1994) Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity. Mol. Cell. Biol., 14, 735-743.
49. Ng, S.-Y., Gunning, P., Eddy, R., Ponte, P., Leavitt, J., Shows, T. and Kedes, L. (1985) Evolution of the functional human b-actin gene and its multi-pseudogene family: conservation of noncoding regions and chromosomal dispersion of pseudogenes. Mol. Cell. Biol., 5, 2720-2732.
50. Nishikawa, R., Ji, X.-D., Harmon, R.C., Lazar, C.S., Gill, G.N., Cavenee, W.K. and Su Huang, H.-J. (1994) A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proc. Natl Acad. Sci. USA, 91, 7727-7731.
51. Padhy, L.C., Shih, C., Cowing, D., Finkelstein, R. and Weinberg, R.A. (1982) Identification of a phosphoprotein specifically induced by the transforming DNA of rat neuroblastomas. Cell, 28, 865-871.
52. Paterson, M.C. et al. (1991) Correlation between c-erbB2 amplification and risk of recurrent disease in node-negative breast cancer. Cancer Res., 51, 556-567.
53. Pinkas-Kramarski, R. et al. (1996) Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions. EMBO J., 15, 2452-2467.
54. Plowman, G.D., Whitney, G.S., Neubauer, M.G., Green, J.M., McDonald, V.L., Todaro, G.J. and Shoyab, M. (1990) Molecular cloning and expression of an additional epidermal growth factor receptor-related gene. Proc. Natl Acad. Sci. USA, 87, 4905-4909.
55. erbB4, a fourth member of the epidermal growth factor receptor family. Proc. Natl Acad. Sci. USA, 90, 1746-1750.
56. Press, M.F. et al. (1993) Her-2/neu expression in node-negative breast cancer: direct tissue quantitaion by computerized image analysis and association of overexpression with increased risk of recurrent disease. Cancer Res., 53, 4960-4970.
57. Prigent, S.A. and Gullick, W.J. (1994) Identification of c-erbB-3 binding sites for phosphatidylinositol 3′-kinase and SHC using an EGF receptor/c-erbB-3 chimera. EMBO J., 13, 2831-2841.
58. Quinn, C.M., Ostrowski, J.L., Lane, S.A., Loney, D.P., Teasdale, J. and Benson, E.A. (1994) c-erbB-3 protein expression in human breast cancer: comparison with other tumour variables and survival. Histopathology, 25, 247-252.
59. Rajikumar, T. and Gullick, W.J. (1994) The type I growth factor receptors in human breast cancer. Breast Cancer Res. Treat., 29, 3-9.
60. Riese, D.J.,II, van Raaji, T.M., Plowman, G.D., Andrews, G.C. and Stern, D.F. (1995) The cellular response to neuregulins is governed by complex interactions of the erbB receptor family. Mol. Cell. Biol., 15, 5770-5776.
61. Robertson, S.C., Meyer, A.N., Hart, K.C., Galvin, B.D., Webster, M.K. and Donoghue, D.J. (1998) Activating mutations in the extracellular domain of the fibroblast growth factor receptor 2 function by disruption of the disulfide bond in the third immunoglobulin-like domain. Proc. Natl Acad. Sci. USA, 95, 4567-4572.
62. Rodrigues, G.A., Naujokas, M.A. and Park, M. (1991) Alternative splicing generates isoforms of the met receptor tyrosine kinase which undergo differential processing. Mol. Cell. Biol., 11, 2962-2970.
63. Santoro, M. et al. (1995) Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. Science, 267, 381-383.
64. Shih, C., Padhy, L.C., Murray, M. and Weinberg, R.A. (1981) Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts. Nature, 290, 261-264.
65. Siegel, P.M. and Muller, W.J. (1996) Mutations affecting conserved cysteine residues within the extracellular domain of Neu promote receptor dimerization and activation. Proc. Natl Acad. Sci. USA, 93, 8878-8883.
66. Siegel, P.M., Dankort, D.L., Hardy, W.R. and Muller, W.J. (1994) Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors. Mol. Cell. Biol., 14, 7068-7077.
67. Slamon, D.J., Clark, G.M., Wong, S.G., Levin, W.J., Ullrich, A. and McGuire, W.L. (1987) Human breast cancer: correlation of relapse and survival with the amplification of the HER-2/neu oncogene. Science, 235, 177-182.
68. Slamon, D.J. et al. (1989) Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science, 244, 707-712.
69. Soltoff, S.P., Carraway, K.L.,III, Prigent, S.A., Gullick, W.J. and Cantley, L.C. (1994) ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor. Mol. Cell. Biol., 14, 3550-3558.
70. neu stimulates tyrosine phosphorylation in vivo. Mol. Cell. Biol., 8, 3969-3973.
71. Stewart, T.A., Pattengale, P.K. and Leder, P. (1984) Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/c-myc fusion genes. Cell, 38, 627-637.
72. Sugawa, N., Ekstrand, A.J., James, C.D. and Collins, V.P. (1990) Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human gliomas. Proc. Natl Acad. Sci. USA, 87, 8602-8606.
73. Tzahar, E., Waterman, H., Chen, X., Levkowitz, G., Karunagaran, D., Lavi, S., Ratzkin, B.J. and Yarden, Y. (1996) A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/Neuregulin and epidermal growth factor. Mol. Cell. Biol., 16, 5276-5287.
74. Ullrich, A. et al. (1984) Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature, 309, 418-425.
75. Vonderhaar, B.K. and Greco, A.E. (1979) Lobulo-alveolar development of mouse mammary glands is regulated by thyroid hormones. Endocrinology, 104, 409-418.
76. Wallasch, C., Weisse, F.U., Niederfellner, G., Jallal, B., Issing, W. and Ullrich, A. (1995) Heregulin-dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3. EMBO J., 14, 4267-4275.
77. Watowich, S.S., Yoshimura, A., Longmore, G.D., Hilton, D.J., Yoshimura, Y. and Lodish, H.F. (1992) Homodimerization and constitutive activation of the erythropoietin receptor. Proc. Natl Acad. Sci. USA, 89, 2140-2144.
78. Webster, M.A. et al. (1998) Requirement for both she and phosphatidylinositol 3′ kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis. Mol. Cell. Biol., 18, 2344-2359.
79. Webster, M.K. and Donoghue, D.J. (1997) FGFR activation in skeletal disorders: too much of a good thing. Trends Genet., 13, 178-182.
80. Weiner, D.B., Kokai, Y., Wada, T., Cohen, J.A., Williams, W.V. and Greene, M.I. (1989a) Linkage of tyrosine kinase activity with transforming ability of the p185neu oncoprotein. Oncogene, 4, 1175-1183.
81. Weiner, D.B., Liu, J., Cohen, J.A., Williams, W.V. and Greene, M.I. (1989b) A point mutation in the neu oncogene mimics ligand induction of receptor aggregation. Nature, 339, 230-231.
82. Wong, A.J., Ruppert, J.M., Bigner, S.H., Grzeschik, C.H., Humphrey, P.A., Bigner, D.S. and Vogelstein, B. (1992) Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proc. Natl Acad. Sci. USA, 89, 2965-2969.
83. Yamamoto, T., Ikawa, S., Akiyama, T., Semba, K., Nomura, N., Miyajima, N., Saito, T. and Toyoshima, K. (1986) Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor. Nature, 319, 230-234.
84. Yao, R. and Cooper, G.M. (1995) Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science, 267, 2003-2006.
85. Zhang, K., Sun, J., Liu, N., Wen, D., Chang, D., Thomason, A. and Yoshinaga, S.K. (1996) Transformation of NIH 3T3 cells by HER3 or HER4 receptors requires the presence of HER1 or HER2. J. Biol. Chem., 271, 3884-3890.
86. Zoll, B., Kynast, B., Corell, B., Marx, D., Fischer, G. and Schauer, A. (1992) Alterations of the c-erbB2 gene in human breast cancer. J. Cancer Res. Clin. Oncol., 118, 468-473.